Medication Safety in Pregnancy?

Help future moms and babies by enrolling into our Actemra® & Pregnancy study.

MotherToBaby is currently enrolling pregnant women in an observational study to explore how rheumatoid arthritis (RA) and its treatment affect pregnancy. All studies are conducted through phone interviews–-no changes to your normal routine or travel required. If you’ve taken Actemra® (tocilizumab) and are pregnant, you may qualify for this important study.‎ 

“There is a huge need to generate more data for all of the drugs that pregnant women need to take.”

— Christina Chambers, PhD MPH, MotherToBaby Pregnancy Studies

MotherToBaby is listed as a resource for information about medications in pregnancy by the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC).

Yes, I’m interested in volunteering in the Actemra® & Pregnancy Study!

Your information is confidential.

Questions? Call 866.626.6847 | Text 855.999.3525 | Email or Chat at

Disclaimer: MotherToBaby Fact Sheets are meant for general information purposes and should not replace the advice of your health care provider. MotherToBaby is a service of the non-profit Organization of Teratology Information Specialists (OTIS). OTIS/MotherToBaby recognizes that not all people identify as “men” or “women.” When using the term “mother,” we mean the source of the egg and/or uterus and by “father,” we mean the source of the sperm, regardless of the person’s gender identity. Copyright by OTIS, March 19, 2019.